Earlier-onset pathology has been consistently noted in females across multiple APP transgenic models, including Tg2576 [120], APP/PS1 [121, 122], an intercross of APPSwe x PS1A246E [123], and 3xTg-AD [124]. This evidence concerns the gene PSEN1 and Alzheimer disease.